Department of Internal Medicine, Division of General Internal Medicine, Section Acute Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, The Netherlands.
Ann Med. 2021 Dec;53(1):402-409. doi: 10.1080/07853890.2021.1891453.
Coronavirus disease 2019 (COVID-19) has a high burden on the healthcare system. Prediction models may assist in triaging patients. We aimed to assess the value of several prediction models in COVID-19 patients in the emergency department (ED).
In this retrospective study, ED patients with COVID-19 were included. Prediction models were selected based on their feasibility. Primary outcome was 30-day mortality, secondary outcomes were 14-day mortality and a composite outcome of 30-day mortality and admission to medium care unit (MCU) or intensive care unit (ICU). The discriminatory performance of the prediction models was assessed using an area under the receiver operating characteristic curve (AUC).
We included 403 patients. Thirty-day mortality was 23.6%, 14-day mortality was 19.1%, 66 patients (16.4%) were admitted to ICU, 48 patients (11.9%) to MCU, and 152 patients (37.7%) met the composite endpoint. Eleven prediction models were included. The RISE UP score and 4 C mortality scores showed very good discriminatory performance for 30-day mortality (AUC 0.83 and 0.84, 95% CI 0.79-0.88 for both), significantly higher than that of the other models.
The RISE UP score and 4 C mortality score can be used to recognise patients at high risk for poor outcome and may assist in guiding decision-making and allocating resources.
2019 年冠状病毒病(COVID-19)给医疗系统带来了沉重负担。预测模型可能有助于对患者进行分诊。我们旨在评估几种预测模型在急诊科(ED)COVID-19 患者中的价值。
在这项回顾性研究中,纳入了 ED 中患有 COVID-19 的患者。根据可行性选择预测模型。主要结局是 30 天死亡率,次要结局是 14 天死亡率以及 30 天死亡率和入住中级护理病房(MCU)或重症监护病房(ICU)的复合结局。使用接受者操作特征曲线下面积(AUC)评估预测模型的区分性能。
我们纳入了 403 名患者。30 天死亡率为 23.6%,14 天死亡率为 19.1%,66 名患者(16.4%)入住 ICU,48 名患者(11.9%)入住 MCU,152 名患者(37.7%)符合复合终点标准。纳入了 11 种预测模型。RISE UP 评分和 4C 死亡率评分对 30 天死亡率具有非常好的区分性能(AUC 分别为 0.83 和 0.84,95%CI 分别为 0.79-0.88),显著高于其他模型。
RISE UP 评分和 4C 死亡率评分可用于识别预后不良风险较高的患者,并可能有助于指导决策和分配资源。